Novi vrsti ajde v Sloveniji / Two new varieties of buckwheat in Slovenia

ANALI PAZU, 9 (2019), št. / No. 1-2, strani / pages 8-15

Celotno besedilo / Full text (PDF)

Povzetek: Bolniki z rakom, ki se zdravijo s kemoterapijo, imajo lahko številne simptome.  V okviru raziskave Mobilna aplikacija za bolnice z rakom dojk na zdravljenju s kemoterapijo ali tarčnimi zdravili, so nam bolnice prek mobilne aplikacije javljale simptome. V naboru je bilo 50 različnih simptomov. Bolnice so označile zaznan simptom, opredelile njegovo jakost (blago, srednje ali hudo) in trajanje. Analizirali smo poročila 16 bolnic za prvi cikel kemoterapije. Srednji čas spremljanja je bil 3 tedne. Najpogostejši simptomi so bili utrujenost (75 %), suha usta, glavobol, rdečica obraza (56 %), bolečine v mišicah, hripavost, zgaga, plini v črevesju (31 %), zaprtje, driska (25 %) in izpadanje las (44 %). Večino simptomov je bilo blage ali srednje stopnje in kratkotrajnih (do 4 dni). Sprotno beleženje simptomov je v pomoč tudi onkologu k boljši terapiji simptomov.

Ključne besede: rak, kemoterapija, simptomi, mobilna apliakcija.

Abstract: Cancer patients on chemotherapy treatment may have several symptoms. In the study Mobile application for patients with breast cancer treated with chemotherapy and targeted therapy, patients reported symptoms by means of the mobile application. Patient could report 50 symptoms. A patient having a specific symptom, defines a severity (mild, moderate or severe) and its duration. We performed analysis on 16 patients for the first cycle of chemotherapy.  The median follow-up was 3 weeks. The most prevalent symptoms were fatigue (75%), dry mouth, headache, redness of the face (56%), myalgia, hoarsenes, heartburn, meteorism (31%), obstipation, diarrhoea (25%) and alopecia (44%). The majority of symptoms were mild or moderate intensity, and short lasting (less then 4 days). Reporting symptoms is of great help for the treating oncologist for better symptom treatment.

Keywords: cancer, chemotherapy, symptoms, mobile application.

Vsi prispevki avtorja: 
Številka revije: